HOME Top Market Reports Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019

Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019

By: marketsandmarkets.com
Publishing Date: January 2015
Report Code: MD 3088

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019. Traditional diagnostic techniques such as immunodiagnostics and biochemical characterization are the largest segments of the IDD market. However, molecular diagnostic techniques, such as microarrays and isothermal nucleic acid amplification technology (INAAT), will show the fastest growth in the forecast period.

The report segments the global infectious disease diagnostics market by product, application, technology, end users and region. On the basis of product, the IDD market is segmented into instruments, consumables, and software & services. Among products, consumables (assays and reagents) are estimated to be the largest market, owing to its growing adoption in emerging infectious disease diagnostics worldwide.

On the basis of application, the infectious disease diagnostics market is segregated into Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, and Dengue included). Hospital-acquired MRSA infections and human papillomavirus (HPV) are expected to be the fastest-growing market segments in the forecast period. This growth is attributed to the growing prevalence of these diseases in recent years.

On the basis of technology, the segment is divided into traditional and molecular diagnostics market. Traditional diagnostics includes immunodiagnostics, microscopy, and biochemical characterization. Molecular diagnostics is further divided into Polymerase Chain Reaction (PCR), INAAT (Isothermal Nucleic Acid Amplification Test), Hybridization, DNA Sequencing & Next-generation Sequencing (NGS), microarrays, and others (flow cytometry, mass spectroscopy, electrophoresis). PCR and INAAT are expected to be the largest market segments. Microarrays, INAAT, and NGS are expected to show the highest growth. This growth is attributed to the need for better sensitivity, specificity and faster turnaround time of diagnostics test for diagnosis of diseases such as HPV, TB, HIV, influenza, hepatitis among others.

On the basis of end users, the market is segmented into hospital laboratories, reference labs, physician office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care, self-testing). Hospital laboratories and reference labs are the largest segments in the IDD market.

The growth of the ORM market is propelled by the increasing prevalence rate of infectious diseases, demand for new rapid diagnostic tests, and increased funding for infectious disease diagnostics by governments. However, rising healthcare costs and the presence of a complex regulatory framework for diagnostics devices are factors hindering the growth of the IDD market.

Key players in this market are Roche Diagnostics (Switzerland), bioMerieux (France), Bio-Rad Laboratories (U.S.), Becton and Dickinson & Co. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

Scope of the Report

Particular

Scope

Geography

  • North America (U.S. and Canada)
  • Europe
  • Asia-Pacific (Asia, Middle-East, and Pacific Countries)
  • RoW (Latin America and Africa)

Historical Years

2012–2013

Base Year

2013

Projected Year

2014

Forecast Period

2014–2019

Revenue Currency

USD ($)

Market Segmentation

This research report categorizes the IDD market on the basis of product, application, technology, end-users and geographies.

By Product

  • Instruments
  • Consumables (Assays and Reagents)
  • Softwares and services

By Application

  • Hepatitis B virus (HBV)
  • Hepatitis C virus (HCV)
  • Acquired Immunodeficiency Syndrome (AIDS)
  • Tuberculosis (TB)
  • Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)
  • Human papillomavirus (HPV) infection
  • Hospital Acquired Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
  • Others (Influenza, Ebola, Typhoid, Malaria, and Dengue among others)

By Technology

  • Traditional Methods
    • Immunodiagnostics
    •  Microscopy
    • Biochemical characterization
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • INAAT (Isothermal Nucleic Acid Amplification Test)
    • Hybridization
    • DNA Sequencing & Next Generation Sequencing
    • Mass Spectroscopy
    • Others

By End-Users

  • Hospitals  laboratories
  • Reference Labs
  • Physician’s office labs
  • Academics
  • Others (blood banks, local public health laboratories, home health agencies, nursing homes, point of care, self-testing)

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents
 
1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Crackdown and Data Triangulation
          2.2.1 Key Data From Secondary Sources
          2.2.2 Key Data From Primary Sources
                   2.2.2.1 Key Industry Insights
          2.2.3 Assumptions

3 Executive Summary

4 Premium Insights
    4.1 Market to Grow at A Modest Rate
    4.2 Market, By Product
    4.3 Global Market, By Application
    4.4 Global Market, By Technique
    4.5 Global Market, By End User
    4.6 Market, By Geography
    4.7 Lifecycle Analysis, By Region

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
          5.2.1 Market, By Product
          5.2.2 Market, By Application
          5.2.2 Market, By Technique
          5.2.3 Market, By End User
    5.3 Market Dynamics
          5.3.1 Drivers
                   5.3.1.1 High Prevalence Rate of Infectious Diseases to Drive the Growth of Idd Market
                   5.3.1.2 Slow Turnaround Time of the Current Diagnostic Cycle Has Created Demand for Rapid Diagnostic Procedures
                   5.3.1.3 New Rapid Diagnostic Tests Hold Promise for the Improved Management and Control of Infectious Diseases
                   5.3.1.4 Increased Funding to Propel the Idd Market
          5.3.2 Restraints
                   5.3.2.1 Rising Healthcare Costs Limits the Usage of Novel Infectious Disease Diagnostic Techniques
                   5.3.2.2 Complex Regulatory Framework to Delay Approvals of New Diagnostic Tests
          5.3.3 Opportunities
                   5.3.3.1 Huge Growth Prospects in Developing Countries
                   5.3.3.2 Advances in Research and Development for Better Diagnostic Procedures to offer New Growth Opportunities
                   5.3.3.3 Personalized Medicine
          5.3.4 Challenges
                   5.3.4.1 Dearth of Trained Professionals Restricting the Appropriate Use of New Diagnostic Tests
                   5.3.4.2 Difficulties Regarding Reimbursement for New Diagnostic Tests May Hamper Innovation
          5.3.5 Winning Imperatives
                   5.3.5.1 Shift in the Focus From Centralized Laboratories to Decentralized Point-of-Care Testing Augmenting the Growth of Idd Market
          5.3.6 Burning Issues
                   5.3.6.1 Global Regulatory Environment Restricting the Clearance and Marketing of Infectious Disease Diagnostic Products

6 Industry Insights
    6.1 Introduction
    6.2 Supply Chain Analysis
          6.2.1 Key Influencers
    6.3 Pest Analysis
          6.3.1 Political Factors
          6.3.2 Economical Factors
          6.3.3 Social Factors
          6.3.4 Technological Factors
    6.4 Industry Insights
    6.5 Strategic Benchmarking
          6.5.1 New Product Launches

7 Infectious Disease Diagnostics Market, By Product
    7.1 Introduction
    7.2 Instruments & Analyzers
    7.3 Consumables
          7.3.1 Assays and Reagents
    7.4 Services & Softwares

8 Infectious Disease Diagnostics Market, By Application
    8.1 Introduction
    8.2 Hepatitis B
    8.3 Hepatitis C
    8.4 Aids
    8.5 Tuberculosis (TB)
    8.6 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
    8.7 Human Papillomavirus (HPV) Infection
    8.8 Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection
    8.9 Others (Influenza, Ebola, Typhoid, Malaria, Dengue)
 
9 Infectious Disease Diagnostics Market, By Technique
    9.1 Introduction
    9.2 Traditional Diagnostic Techniques
          9.2.1 Immunodiagnostics
          9.2.2 Microscopy
          9.2.3 Biochemical Characterization
    9.3 Molecular Diagnostics
          9.3.1 PCR
          9.3.2 INAAT
          9.3.3 Hybridization
          9.3.4 DNA Sequencing & NGS 
          9.3.5 Microarray
          9.3.6 Others 
 
10 Infectious Disease Diagnostics Market, By End User
     10.1 Introduction
     10.2 Hospitals  Laboratories
     10.3 Reference Labs
     10.4 Physician office Labs
     10.5 Academics (Acadmic Medical Centers/Research Labs, University Labs)
     10.6 Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point of Care, Self Testing)
 
11 Geographic Analysis
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
     11.4 Asia-Pacific
     11.5 Rest of the World (ROW)

12 Competitive Landscape
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Battle for Market Share: New Product Launches Was the Key Strategy
     12.4 New Product Launches
     12.5 Agreements, Partnerships, and Collaborations
     12.6 Acquisitions
     12.7 Expansions
     12.8 Other Developemnts

13 Company Profile
     13.1 Abbott Laboratories
             13.1.1 Business Overview
             13.1.2 Product Portfolio
             13.1.3 Key Strategy
             13.1.4 Recent Developments
     13.2 Becton, Dickinson & Co.
             13.2.1 Business Overview
             13.2.2 Product Portfolio
             13.2.3 Key Strategy
             13.2.4 Recent Developments
     13.3 Biomérieux
             13.3.1 Business Overview
             13.3.2 Product Portfolio
             13.3.3 Key Strategy
             13.3.4 Recent Developments
             13.3.5 SWOT Analysis
             13.3.6 MNM View
     13.4 Bio-Rad Laboratories
             13.4.1 Business Overview
             13.4.2 Products & Services
             13.4.3 Key Strategy
             13.4.4 Recent Developments
     13.5 Alere, Inc.
             13.5.1 Business Overview
             13.5.2 Product Portfolio
             13.5.3 Key Strategy
             13.5.4 Recent Developments
     13.6 Thermo Fisher Scientific, Inc.
             13.6.1 Products & Services
             13.6.2 Key Strategy
             13.6.3 Recent Developments
     13.7 Siemens Healthcare
             13.7.1 Business Overview
             13.7.2 Key Strategy
             13.7.3 Recent Developments
     13.8 Roche Diagnostics
             13.8.1 Business Overview
             13.8.2 Product Portfolio
             13.8.3 Key Strategy
             13.8.4 Recent Developments
     13.9 Danaher Corporation
             13.9.1 Business Overview
             13.9.2 Product Portfolio
             13.9.3 Key Strategy
             13.9.4 Recent Developments
     13.10 Johnson and Johnson
             13.10.1 Business Overview
             13.10.2 Product Portfolio
             13.10.3 Key Strategy
             13.10.4 Recent Developments

14 Appendix
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Introducing RT: Real-Time Market Intelligence
     14.4 Available Customizations
     14.5 Related Reports
 
List of Tables (97 Tables)
 
Table 1 Global Market Size, By Product, 2012–2019 ($Million)
Table 2 Market Size for Instruments, By Geography, 2012-2019 ($Million)
Table 3 North American Infectious Disease Diagnostics Market Size for Instruments, By Country, 2012-2019 ($Million)
Table 4 Market Size for Reagents, By Geography, 2012-2019 ($Million)
Table 5 North American Infectious Disease Diagnostics Market Size for Reagents, By Country, 2012-2019 ($Million)
Table 6 Market Size for Services and Softwares, By Geography, 2012-2019 ($Million)
Table 7 ROW Fluorescence Infectious Disease Diagnostics Market Size, By Country, 2012-2019 ($Million)
Table 8 North American Infectious Disease Diagnostics Market Size for Services and Softwares, By Country, 2012-2019 ($Million)
Table 9 Global Infectious Disease Diagnostics Market Size, By Technique, 2012–2019 ($Million)
Table 10 Global Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 11 Global Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 12 Market Size for Immunodiagnostics, By Geography, 2012-2019 ($Million)
Table 13 North American Infectious Disease Diagnostics Market Size for Immunodiagnostics, By Country, 2012-2019 ($Million)
Table 14 Market Size for Microscopy, By Geography, 2012-2019 ($Million))
Table 15 North American Infectious Disease Diagnostics Market Size for Microscopy, By Country, 2012-2019 ($Million)
Table 16 Market Size for Biochemical Characterization, By Geography, 2012-2019 ($Million)
Table 17 North American Infectious Disease Diagnostics Market Size for Biochemical Characterization, By Country, 2012-2019 ($Million)
Table 18 Market Size for PCR, By Geography, 2012-2019 ($Million)
Table 19 North American Infectious Disease Diagnostics Market Size for PCR, By Country, 2012-2019 ($Million)
Table 20 Market Size for INAAT, By Geography, 2012-2019 ($Million)
Table 21 North American Infectious Disease Diagnostics Market Size for INAAT, By Country, 2012-2019 ($Million)
Table 22 Market Size for Hybridization, By Geography, 2012-2019 ($Million)
Table 23 North American Infectious Disease Diagnostics Market Size for Hybridization, By Country, 2012-2019 ($Million)
Table 24 Market Size for DNA Sequencing & NGS, By Geography, 2012-2019 ($Million)
Table 26 North American Infectious Disease Diagnostics Market Size for DNA Sequencing & NGS, By Country, 2012-2019 ($Million)
Table 27 Market Size for Microarray, By Geography, 2012-2019 ($Million)
Table 28 North American Infectious Disease Diagnostics Market Size for Microarray, By Country, 2012-2019 ($Million)
Table 29 Market Size for Others, By Geography, 2012-2019 ($Million)
Table 30 North American Infectious Disease Diagnostics Market Size for Others, By Country, 2012-2019 ($Million)
Table 31 Global Infectious Disease Diagnostics Market Size, By Application, 2012–2019 ($Million)
Table 32 Market Size for Hepatitis B, By Geography, 2012-2019 ($Million)
Table 33 North American Infectious Disease Diagnostics Market Size for Hepatitis B, By Country, 2012-2019 ($Million)
Table 34 Market Size for Hepatitis C, By Geography, 2012-2019 ($Million)
Table 35 North American Infectious Disease Diagnostics Market Size for Hepatitis C, By Country, 2012-2019 ($Million)
Table 36 Market Size for Aids, By Geography, 2012-2019 ($Million)
Table 37 North American Infectious Disease Diagnostics Market Size for Aids, By Country, 2012-2019 ($Million)
Table 38 Market Size for Tuberculosis, By Geography, 2012-2019 ($Million)
Table 39 North American Infectious Disease Diagnostics Market Size for Tuberculosis, By Country, 2012-2019 ($Million)
Table 40 Market Size for CT/NG, By Geography, 2012-2019 ($Million)
Table 41 Market Size for HPV, By Geography, 2012-2019 ($Million)
Table 42 Market Size for MRSA (Hospital Acquired Infection), By Geography, 2012-2019 ($Million)
Table 43 Market Size for Others, By Geography, 2012-2019 ($Million)
Table 44 Global Market Size, By End User, 2012–2019 ($Million)
Table 45 North America: Electron Market Size, By Type, 2012–2019 ($Million)
Table 46 Hospital Laboratories Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million)
Table 47 North America Hospital Laboratories Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
Table 48 Reference Labs Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million)
Table 49 North America Reference Labs Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
Table 50 Physician office Labs Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million))
Table 51 North America Physician office Labs Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
Table 52 Academics Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million))
Table 53 North America Academics Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
Table 54 Other End Users Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million)
Table 55 North America Other End Users Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
Table 56 Global Infectious Disease Diagnostics Market Size, By Region, 2012-2019 ($Million)
Table 57 North America: Market Size, By Country, 2012-2019 ($Million)
Table 58 North America: Market Size, By Technique, 2012-2019 ($Million)
Table 59 North America: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 60 North America: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 61 North America: Market Size, By Product, 2012-2019 ($Million)
Table 62 North America: Market Size, By Application, 2012-2019 ($Million)
Table 63 North America: Market Size, By End User, 2012-2019 ($Million)
Table 64 U.S. Market Size, By Technique, 2012-2019 ($Million)
Table 65 U.S. Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 66 U.S. Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 67 U.S. Market Size, By Product, 2012-2019 ($Million)
Table 68 U.S. Market Size, By Application, 2012-2019 ($Million)
Table 69 U.S. Market Size, By End User, 2012-2019 ($Million)
Table 70 Canada: Market Size, By Technique, 2012-2019 ($Million)
Table 71 Canada: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 72 Canada: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 73 Canada: Market Size, By Product, 2012-2019 ($Million)
Table 74 Canada: Market Size, By Application, 2012-2019 ($Million)
Table 75 Canada: Market Size, By End User, 2012-2019 ($Million)
Table 76 Europe: Market Size, By Technology, 2012-2019 ($Million)
Table 77 Europe: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 78 Europe: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 79 Europe: Market Size, By Application, 2012-2019 ($Million)
Table 80 Europe: Market Size, By End User, 2012-2019 ($Million)
Table 81 Asia-Pacific: Market Size, By Technique, 2012-2019 ($Million)
Table 82 Asia-Pacific: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 83 Asia-Pacific: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 84 Asia-Pacific: Market Size, By Product, 2012-2019 ($Million)
Table 85 Asia-Pacific: Market Size, By Application, 2012-2019 ($Million)
Table 86 Asia-Pacific: Market Size, By End User, 2012-2019 ($Million)
Table 87 ROW: Market Size, By Technique, 2012-2019 ($Million)
Table 88 ROW: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 89 ROW: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012–2019 ($Million)
Table 90 ROW: Market Size, By Product, 2012-2019 ($Million)
Table 91 ROW: Market Size, By Application, 2012-2019 ($Million)
Table 92 ROW: Market Size, By End User, 2012-2019 ($Million)
Table 93 New Product Launches, 2011–2014
Table 94 Agreements, Partnerships, and Collaborations, 2011–2014
Table 95 Acquisitions, 2011–2014
Table 96 Expansions 2011-2014
Table 97 Other Developments, 2011–2014
 
List of Figures (35 Figures)
 
Figure 1 Research Methodology
Figure 2 Market Size Estimation
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Snapshot (2014 Vs. 2019)
Figure 5 Global Market, By Application, 2014
Figure 6 Hospital Laboratories Are the Major End Users of the Market
Figure 7 Geographical Snapshot, 2014
Figure 8 New Product Launch is the Dominant Strategy Among the Market Players
Figure 9 Technological Advancements and Favorable Government Funding Are Important Growth Drivers
Figure 10 Consumables to Account for the Largest Share in Market
Figure 11 Asia-Pacific to Grow at the Highest Rate During the forecast Period
Figure 12 Hepatitis B Segment to Dominate the Infectious Disease Diagnostics Applications Market in 2014
Figure 13 Hospital Laboratories Are the Major End Users of the Market
Figure 14 Asia-Pacific Market Showcases Lucrative Growth Opportunities
Figure 15 Market Segmentation, By Product
Figure 16 Market Segmentation, By Application
Figure 17 Market Segmentation, By End User
Figure 18 Favorable Government & Corporate Funding to Boost Market Growth
Figure 19 Supply Chain Analysis
Figure 20 Development of POC Diagnostic Techniques is the Leading Trend Among Key Players
Figure 21 Market Players Adopted the Organic Growth Strategy of New Product Launches
Figure 22 Traditional Diagnostic Techniques  Accounts for the Largest Share of the Overall Market in 2014
Figure 23 Infectious Disease Immunodiagnostics Segment Dominates the Traditional Diagnostic Techniques  Market
Figure 24 Companies Adopted Product Innovation As Their Key Growth Strategy Over the Last Three Years
Figure 25 Global Market Share, By Key Player, 2013
Figure 26 Abbott Laboratories: Company Snapshot
Figure 27 Becton, Dickinson & Co.: Company Snapshot
Figure 28 Biomérieux: Company Snapshot
Figure 29 Bio-Rad Laboratories: Company Snapshot
Figure 30 Alere, Inc.: Company Snapshot
Figure 31 Thermo Fisher Scientific, Inc: Company Snapshot
Figure 32 Siemens Healthcare: Company Snapshot
Figure 33 Roche Diagnostics.: Company Snapshot
Figure 34 Danaher Corporation: Company Snapshot
Figure 35 Johnson and Johnson: Company Snapshot

The infectious disease diagnostics market is expected to grow at CAGR of 7.9% to reach $18,156.2 million by 2019 from $12,422.8 million in 2014. Increase in governmental funding for diagnoses of infectious diseases, growing prevalence rate of infectious diseases, and the development of highly advanced rapid diagnostic tests for better management of infectious diseases are major factors driving the growth of global market.

The market is segmented on the basis of products (instruments, consumables, and software & services), applications (Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) infection, Human papillomavirus (HPV), Methicillin-resistant Staphylococcus aureus (MRSA) and others (Influenza, Ebola, Typhoid, Malaria, and Dengue included), technology (traditional methods (immunodiagnostics, microscopy, and biochemical characterization), and molecular diagnostics (Polymerase Chain Reaction (PCR), INAAT (Isothermal Nucleic Acid Amplification Test)), Hybridization, DNA Sequencing & NGS, microarray, and others (flow cytometry, mass spectroscopy, electrophoresis), end users (hospital laboratories, reference labs, physician office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care, self-testing)), and regions (North America, Europe, Asia-Pacific, and RoW).

On the basis of technology, the segment is divided into traditional and molecular diagnostics. Traditional diagnostics is further categorized into immunodiagnostics, microscopy, and biochemical characterization. Molecular diagnostics is divided into PCR, INAAT, Hybridization, DNA Sequencing & NGS, microarrays, and others (flow cytometry, mass spectroscopy, electrophoresis). PCR and INAAT are expected to be the largest market segments in the forecast period. Microarray, INAAT, and NGS are expected to be the fastest-growing markets. The need for faster detection of diseases and the demand for advanced technologies with better specificity and sensitivity are the major drivers of this segment.

On the basis of application, MRSA, Human papillomavirus (HPV), and AIDS are expected to be the fastest-growing segments in the forecast period. This growth is attributed to the growing prevalence of these diseases in recent years.

Geographically, the infectious disease diagnostics market is dominated by North America, followed by Europe. However, the Asia-Pacific region is expected to grow at the highest CAGR of 9.9% during the forecast period. This growth is attributed to the growing prevalence of infectious disease (tuberculosis, hepatitis and HIV) in countries such as China, India, Japan and Australia. Besides these, various awareness programs regarding prevention of infectious disease are conducted in countries such as Singapore, Australia and Malaysia.

Major players operating in the global infectious disease diagnostics market are Roche Diagnostics (Switzerland), bioMerieux (France), Bio-Rad Laboratories (U.S.), Becton and Dickinson & Co. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

Global Infectious Disease Diagnostics Market, by Application 2014

Infectious Disease Diagnostics Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports